CN1289061C - 用于预防和治疗臭汗症的药剂 - Google Patents

用于预防和治疗臭汗症的药剂 Download PDF

Info

Publication number
CN1289061C
CN1289061C CNB028185765A CN02818576A CN1289061C CN 1289061 C CN1289061 C CN 1289061C CN B028185765 A CNB028185765 A CN B028185765A CN 02818576 A CN02818576 A CN 02818576A CN 1289061 C CN1289061 C CN 1289061C
Authority
CN
China
Prior art keywords
botulinum toxin
body odor
odor
skin
sweat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028185765A
Other languages
English (en)
Chinese (zh)
Other versions
CN1556693A (zh
Inventor
马克·海克曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CN1556693A publication Critical patent/CN1556693A/zh
Application granted granted Critical
Publication of CN1289061C publication Critical patent/CN1289061C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028185765A 2001-09-21 2002-09-23 用于预防和治疗臭汗症的药剂 Expired - Fee Related CN1289061C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146647.1 2001-09-21
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis

Publications (2)

Publication Number Publication Date
CN1556693A CN1556693A (zh) 2004-12-22
CN1289061C true CN1289061C (zh) 2006-12-13

Family

ID=7699852

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028185765A Expired - Fee Related CN1289061C (zh) 2001-09-21 2002-09-23 用于预防和治疗臭汗症的药剂

Country Status (16)

Country Link
US (1) US20050036966A1 (enExample)
EP (2) EP1427385B1 (enExample)
JP (1) JP4966478B2 (enExample)
KR (1) KR100796243B1 (enExample)
CN (1) CN1289061C (enExample)
AU (1) AU2002349268B2 (enExample)
CA (1) CA2461117C (enExample)
DE (1) DE10146647A1 (enExample)
EA (2) EA011988B1 (enExample)
HU (1) HU230398B1 (enExample)
IL (2) IL160875A0 (enExample)
MX (1) MXPA04002614A (enExample)
PL (1) PL209639B1 (enExample)
UA (1) UA78718C2 (enExample)
WO (1) WO2003026602A2 (enExample)
ZA (1) ZA200402123B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
EP2272340B1 (en) 2002-08-19 2018-03-14 Ira Sanders Botulinum toxin
US7335367B2 (en) * 2003-03-06 2008-02-26 Botulinum Toxin Research Associates, Inc. Treatment of chronic chalazion and hordeolum with botulinum toxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CN101848702B (zh) 2006-12-01 2013-07-17 安特里奥公司 两亲实体纳米粒子
MX2010013562A (es) * 2008-06-26 2011-02-15 Anterios Inc Aplicacion dermica.
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US11191819B2 (en) 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Also Published As

Publication number Publication date
EP1427385B1 (de) 2015-09-23
IL160875A (en) 2010-11-30
PL209639B1 (pl) 2011-09-30
KR20040048895A (ko) 2004-06-10
EA200400436A1 (ru) 2007-02-27
AU2002349268B2 (en) 2007-12-13
DE10146647A1 (de) 2003-04-24
WO2003026602A3 (de) 2003-08-28
MXPA04002614A (es) 2005-02-17
EP2987483B1 (de) 2020-12-02
UA78718C2 (en) 2007-04-25
JP2005507888A (ja) 2005-03-24
EA008146B1 (ru) 2007-04-27
HUP0401913A3 (en) 2008-02-28
JP4966478B2 (ja) 2012-07-04
CA2461117A1 (en) 2003-04-03
US20050036966A1 (en) 2005-02-17
EA011988B1 (ru) 2009-06-30
PL373528A1 (en) 2005-09-05
CA2461117C (en) 2009-12-08
CN1556693A (zh) 2004-12-22
EA200601238A1 (ru) 2007-06-29
HU230398B1 (hu) 2016-04-28
KR100796243B1 (ko) 2008-01-21
EP2987483A1 (de) 2016-02-24
HUP0401913A2 (hu) 2005-01-28
IL160875A0 (en) 2004-08-31
ZA200402123B (en) 2004-10-04
WO2003026602A2 (de) 2003-04-03
EP1427385A2 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
Benohanian Antiperspirants and deodorants
Indurkar et al. Effect of ozonated oil and chlorhexidine gel on plaque induced gingivitis: A randomized control clinical trial
CN1556693A (zh) 用于预防和治疗臭汗症的药剂
US20060110439A1 (en) Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
EP3621653A1 (en) Skin barrier composition
WO2011119247A2 (en) Topical skincare composition
Joseph et al. Tongue pathology
Ballantyne et al. Dermal sensitizing potential of glutaraldehyde: a review and recent observations
US11304973B2 (en) Botulinum toxin and colloidal silver particles
CN111093611B (zh) 用于在降低或预防体味时应用的短杆菌素及其制剂
CN1585642A (zh) 包含3,4－丙炔基全氢化嘌呤的药物组合物及其在阻滞神经元传递方面的应用
JP2000290163A (ja) 保湿クリーム
Pessemier et al. Underarm body odor, the microbiome, and probiotic treatment
RU2819716C1 (ru) Способ лечения себорейного дерматита волосистой части головы
KR20210042616A (ko) 왁스형 클렌저
Moftah et al. Intralesional vitamin D3 versus glycolic acid 70% peeling in pseudo-acanthosis nigricans treatment: a randomized comparative study
CN121512867A (zh) 除臭露
Tyagi et al. Comparative Evaluation of the Effect of Various Cavity Disinfectants on Shear Bond Strength of Composite Resin to Dentin
Raab Aromatherapy in the intensive care unit: An overview
Herizchi et al. Treatment of erythrasma: a double-blinded randomized controlled trial on the clinical application of clotrimazole and sertaconazole
Ramanan et al. DIABETIC FOOT CREAM AND MARKET RESEARCH OF CLOTRIMAZOLE MOLECULE.
JP2022183707A (ja) 皮膚常在菌叢制御用組成物
CN1875942A (zh) 抑汗、除臭外用喷雾剂配方
Sinclair et al. Hyperhidrosis and bromhidrosis A guide to assessment and management

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ALEGAN CO.,LTD.

Free format text: FORMER OWNER: MAKEHAIKEMAN

Effective date: 20060127

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20060127

Address after: American California

Applicant after: ALLERGAN, Inc.

Address before: German Bochim

Applicant before: Heckmann Marc

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061213

Termination date: 20210923

CF01 Termination of patent right due to non-payment of annual fee